Salomon and Arc'teryx Help Amer Sports Defy Downturn With Athleisure Bet
In 2020, Carlo Aragon started the 'Salomonology' Instagram page as a fashion moodboard to help him decide whether to invest $150 in a pair of Salomon XT-6s.
He bought it, liking how the shoes looked 'unorthodox.' Others did too — the account now has almost 150,000 followers, intrigued by how trail shoes can pair with streetwear.
Aragon's Instagram fame mirrors the ascent of Amer Sports Inc., the company behind Salomon. Since its New York Stock Exchange debut in February 2024, the Helsinki-based group, which also owns outerwear brand Arc'teryx and sports equipment maker Wilson, has nearly tripled its market value to $21 billion. It has outpaced peers like On Holding AG, Hoka parent company Deckers Outdoor Corp. and Anta Sports Products Ltd., the Chinese sporting goods giant that owns a 42% stake in Amer Sports.
Amer Sports' growth has beaten the consumer downturn by riding the outdoor activity wave. It's among the mid-tier luxury brands offering shoppers high-quality goods that don't break the bank.
The bulk of this rally occurred recently, following first-quarter results that defied a rocky global economy. Sales topped expectations, and the company raised its outlook while others cut theirs.
Growth of its Technical Apparel and Outdoor Performance divisions — which respectively house Arc'teryx and Salomon — boosted results, Chief Executive Officer James Zheng said in the most recent earnings call, highlighting the brands' potential.
While Salomon sneakers surpassed $1 billion in sales in 2024, it's a fraction of the $180 billion global sneaker market, and Arc'teryx is 'very under-penetrated globally,' he said in the call. Amer Sports declined a request for an interview with an executive.
Reversal of fortunes
Amer Sports wasn't always this successful.
Shares remained subdued after the IPO due to high debt, low trading volume, and significant exposure to a lagging Chinese economy, said Laurent Vasilescu, an analyst at BNP Paribas Exane, who rates the stock outperform.
Then in December, Amer Sports issued shares to pay down most of its debt. This move reduced leverage and boosted trading volume, alleviating two of the three primary investor concerns, Vasilescu said in an interview. China, which accounts for about 30% of the company's revenue, remains a concern, though sales in the market have bested expectations every quarter since the IPO.
Premium sportswear and outdoor market gear is one of the fastest-growing consumer segments in China, attracting younger and female consumers, as well as luxury shoppers, Chief Financial Officer Andrew Page said on the earnings call.
Glamping — short for glamorous camping — and gorpcore – wearing outdoor clothes as everyday wear – are currently trending in China, Vasilescu said. Amer Sports is also attracting middle- and upper-income customers who like the 'quiet luxury' aesthetic and the upscale in-store shopping experience of its brands, he added.
That's happening in the US too, where celebrities like Timothée Chalamet and Bella Hadid have been spotted wearing Salomon shoes. Sales in its Americas division have grown every year since 2020 – the earliest publicly available results – though at a slower pace than Greater China's, which is estimated to overtake Europe, the Middle East and Africa as Amer Sports' second-largest market by revenue this year.
One fan is Gabriella Gonzalez, a 29-year-old stylist who popped by a Salomon store in New York City's SoHo shopping district on a Friday afternoon. She praised the breathability, waterproofing and style of her pink-and-black XT-6 shoes. 'They make my outfits pop,' she said.
About half a mile away is Arc'teryx's largest US store. Customer Chris Rojes said he doesn't mind paying more for Arc'teryx's gear over other brands. 'You feel more special in them.'
Arc'teryx distinguishes itself from other outdoor apparel brands like Patagonia Inc. and VF Corp's The North Face through a 'much higher level of premiumization,' said TD Cowen analyst John Kernan, who has a buy rating on Amer Sports. Despite higher prices, consumers are willing to pay for Arc'teryx's 'leading innovation.'
Declining consumer brand loyalty and a growing desire for variety also creates an opportunity for Salomon and Arc'teryx to gain market share from industry leaders like Nike Inc. and Adidas AG, Vasilescu said.
To keep flying high, Amer Sports needs to go global, analysts said, warning that it's an uphill battle.
'We believe that the global brand rollout will not be easy' due to Arc'teryx's high price points and intense competition in Western outerwear markets, said HSBC analyst Akshay Gupta, who has a hold rating on the company.
Morningstar analyst Ivan Su, who has a sell rating, believes Amer Sports' would need a compound annual growth rate of 20% over the next five years to support its currently high valuation, which would require 'near flawless execution' globally.
By Rachel Phua and Rachel Yeo
Learn more:
Amer Sports Raises 2025 Guidance on Strong Demand for Arc'teryx and Salomon Footwear
Shares of the athletic apparel and equipment maker hit an all-time high on Tuesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Xobee Networks Announces Appointment of Scott Brueggeman as Chief Revenue Officer
FRESNO, Calif--(BUSINESS WIRE)--O2 Investment Partners ( is pleased to announce that Xobee Networks ( a leading managed service provider, has appointed Scott Brueggeman as its Chief Revenue Officer. Scott brings a unique combination of strategic vision and hands-on experience scaling revenue at growth-oriented businesses. His leadership will be instrumental as we continue to invest in Xobee's expansion and build a best-in-class go-to-market engine. Mr. Brueggeman brings more than 25 years of leadership experience across technology, infrastructure, and business services companies, with a particular focus on sales, marketing, and go-to-market strategy. Most recently, he served as Chief Marketing Officer at Core Scientific (NASDAQ: CORZ), where he led the company's strategic pivot into AI-driven high-performance computing infrastructure. Prior to that, he held senior executive roles at Logix Fiber Networks, CyrusOne, and CoreLink Data Centers, driving transformational growth, go-to-market realignment, and successful M&A integrations totaling over $1 billion in enterprise value. managed service, SaaS, data center, and telecom—making him well-positioned to lead Xobee's next phase of growth. Mr. Brueggeman commented, 'I'm thrilled to be joining Xobee at such an exciting time in its growth. The company has built an impressive foundation and a reputation for delivering reliable, high-touch IT services. I'm eager to work with the team to drive meaningful growth and further strengthening how we serve and support our customers.' Eric Rawn, Founder of Xobee, stated, 'Scott's appointment marks a key milestone for Xobee. His experience leading growth and go-to-market strategy in both large-scale and high-growth businesses makes him an exceptional fit. I'm excited to collaborate with him as we take Xobee to the next level.' Sam Wegenke at O2 added, 'Scott brings a unique combination of strategic vision and hands-on experience scaling revenue at growth-oriented businesses. His leadership will be instrumental as we continue to invest in Xobee's expansion and build a best-in-class go-to-market engine.' About Xobee Founded in 1996, Xobee Networks is a premier managed service provider offering comprehensive IT solutions to businesses throughout California. The company provides outsourced IT services, cybersecurity, cloud infrastructure, VoIP, and data backup solutions to a diverse base of SMB and enterprise clients. Xobee is headquartered in Fresno, California. Additional information is available at About O2 Investment Partners O2 Investment Partners is a Midwestern-based private equity firm that seeks to invest in lower middle market B2B services, technology, and select industrial companies. The firm invests in businesses with earnings growth potential and a clear path to the creation of shareholder value. O2 invests with a view toward partnering with management to build and grow the business and take it to its next stage of development. Additional information is available at
Los Angeles Times
an hour ago
- Los Angeles Times
Insurer Blue Shield of California's new parent company alarms consumer advocates
Last year, regulators approved a request by Blue Shield of California, the state's third-largest health insurer, to restructure and establish a new parent corporation in Delaware. The Oakland-based nonprofit got the go-ahead from the Department of Managed Health Care, or DMHC, to create an entity called Ascendiun Inc., which is now the out-of-state corporate parent of Blue Shield. The insurer said that the restructuring would allow it to better serve its members 'with less bureaucracy and faster results, while making health care more affordable.' But the transaction has raised alarm among a former high-level Blue Shield executive and consumer advocates, who complain that it was carried out with no public oversight and could allow the insurer to transfer money to a Delaware parent company with few strings attached. The activists claim that some of that money could be used to boost its spending on charitable endeavors. The company has accrued a surplus of more than $4 billion over the decades as it benefited from its former tax-exempt status, according to a regulatory filing. 'The move guts the ability of the DHMC to enforce Blue Shield's nonprofit obligations to the California public and gives Blue Shield's directors ... a virtually free hand to make use of Blue Shield's billions of dollars in charitable assets as they please,' wrote Michael Johnson, the insurer's former vice president of public policy, in a recent letter to Mary Watanabe, director of the department, which was reviewed by The Times. Johnson is calling for the department to rescind its approval and unwind the restructuring. The department maintains that the insurer is not subject to charitable trust rules as a nonprofit mutual benefit corporation. In a statement, the department said it 'maintains full regulatory authority and enforcement of all Blue Shield of California health plan operations,' and reviewed the transaction to ensure that it will not harm the plan's financial viability. Blue Shield's restructuring is reviving a longstanding debate about whether one of the state's largest insurers is reinvesting enough of its profit to lower its rates, better serve low-income residents and provide coverage for underserved areas of the state. Controversy over the company's role as a nonprofit previously aired in 2015 as it sought approval from the department for its $1.2-billion purchase of Care1st, a Medicaid health plan. Blue Shield has disputed Johnson's claims, noting that the state has determined it is not subject to the rules governing charitable nonprofits. In the Jan. 8 announcement of its restructuring, Blue Shield also disclosed that it was forming a for-profit subsidiary called Stellarus that would provide services to other health plans, such as delivering drugs to patients more inexpensively than pharmacy benefit managers. Ascendiun is structured as a nonprofit and Blue Shield and the company's Medi-Cal insurer, Blue Shield of California Promise Health Plan — the former Care1st — also would continue as nonprofits, the insurer said at the time. 'This structure is not uncommon among health plans, as many across the country — including other nonprofit Blue Cross and Blue Shield companies — have made similar corporate reorganizations to better serve their membership,' the insurer said in its statement to The Times. Blue Shield was established in 1939 by the California Medical Assn. as the nation's first prepaid health plan to cover physician bills. It followed the creation of the first Blue Cross plan, in Texas, to pay for hospital bills. The California insurer did not pay federal taxes until a change in the law in 1986. And it was exempt from state taxes until the Franchise Tax Board revoked that status in August 2014 after a scathing audit that The Times first reported. The audit found that Blue Shield was operating similarly to a for-profit company, with executives instructed to 'maximize profitability.' The tax board also found that the insurer had stockpiled 'extraordinarily high surpluses' even as it failed to offer enough public benefits, such as more affordable coverage. Blue Shield denied the accusations but ultimately relinquished its tax-exempt status, even as it has continued to pursue an appeal of an order requiring it to pay more than $100 million in back taxes. Johnson contends that the new corporate structure will allow Blue Shield to move its assets around in pursuit of its business goals with little oversight beyond maintaining required reserves — especially given its parent company's incorporation in Delaware, a business-friendly state where most Fortune 500 companies are registered. The DMHC strengthened reserve requirements in approving the deal and it now totals about $2.1 billion, according to a regulatory filing, which Johnson says would allow Blue Shield to transfer about $2.4 billion to Ascendiun. Charles Bell, a healthcare advocate who was involved in last decade's debate over Blue Shield's charitable obligations, is troubled by the decision to establish an out-of-state parent. 'I think that the changes in corporate structure that were made are highly concerning, and it should have received a much higher level of public scrutiny and a lot more skepticism by the Department of Managed Health Care,' said Bell, advocacy programs director for Consumers Union, the publisher of Consumer Reports. The department said in its response to The Times that it 'may hold public meetings if a transaction meets certain requirements to qualify as a major transaction. Upon due consideration, the Department determined that the specific facts of this restructuring did not meet the criteria set out in law to hold a public meeting.' Blue Cross and Blue Shield plans have a long history of restructuring, including Blue Cross of California. That insurer broke ground when in 1993 it spun off a recently established for-profit subsidiary, Wellpoint Health Networks. Blue Cross was later required to distribute $3.2 billion to a pair of new nonprofits, the California Endowment and the California Health Care Foundation, which are still operating. Less than a decade later, Blue Cross and Blue Shield plans in more than dozen other states had converted to for-profits, typically highly controversial proposals, given questions about what was to become of their billions of dollars of assets. More recently, the nonprofits have converted into mutual insurance holding companies. That allows them to maintain their nonprofit status while funding for-profit ventures, such as in technology, said Brendan Bridgeland, an attorney with the Center for Insurance Research in Cambridge, Mass. What is unusual about Blue Shield of California's restructuring, he said, is that the DMHC allowed it to establish an out-of-state parent company. 'Once you reach the point where the subsidiary starts transferring money up to the parent and it gets reallocated, then it's going to be out of their control,' Bridgeland said. Johnson's concerns are rooted in efforts last decade by healthcare advocates to have Blue Shield declared a charitable organization and to dig into its assets to improve patient care as a condition of its approval to acquire Care1st. Johnson worked at Blue Shield from 2003 until 2015, when he resigned to mount a public campaign to pressure the insurer over its nonprofit mission. Johnson has been involved in litigation with his former employer, which sued him in 2015 alleging he disclosed confidential information, including Blue Shield's communications with the Franchise Tax Board. In a settlement, he agreed to no longer retain or disseminate such documents. In seeking to retain its state tax-exemption during its audit by the board, which began in 2013, Blue Shield argued that should it dissolve, its assets could be distributed only to another nonprofit. Yet, the insurer told the DMHC, when the agency reviewed the proposed acquisition in 2015, that as a nonprofit mutual-benefit corporation it served only its enrollees and had no such obligations. Ultimately, the department decided that Blue Shield did not have the charitable obligations though it required the insurer, in approving the acquisition that year, to refrain from making 'misleading or inconsistent' statements regarding the distribution of its assets if it ever were dissolved. 'Through this process there have been inconsistencies in what Blue Shield has said. It was frustrating because we had to spend a lot of time and energy to make sure what was true,' the department's then director, Shelley Rouillard, said at the time. The insurer pledged as part of the Care1st acquisition to spend $200 million over the next decade on several initiatives aimed at providing better patient care. Nevertheless, patient advocates criticized the DMHC's finding that Blue Shield did not have charitable obligations, saying the state lost the opportunity to regulate how the insurer spent its billions in assets — and then failed to impose tougher conditions on the insurer, such as limiting its ability to impose rate increases deemed unreasonable. In his March letter, Johnson called on the DMHC to require Blue Shield to spend annually at least 5% of its total assets on community benefits, which might go, for example, to grants to community clinics in underserved areas of the state. Blue Shield defended its charitable spending, noting that it caps its annual profit at 2% and allocates additional revenue to such services as delivering COVID vaccines at no cost to the state, and funding nonprofits that advance mental health. 'Blue Shield … has consistently supported its members and California communities throughout the state,' the company said. Johnson also contends newly public documents show Blue Shield has continued to argue before state tax authorities that it is a charitable trust. In the opening brief of its back taxes case in 2020, the insurer cites a state Supreme Court case that it said confirms 'Blue Shield operates exclusively for the promotion of social welfare,' his letter notes. Blue Shield told The Times that it has provided 'consistent information to DMHC about its corporate restructuring' and that Johnson's letter provided 'no new evidence' regarding Blue Shield's status as a 'tax-paying not-for-profit mutual benefit corporation.' Johnson and the DMHC traded additional letters last week, with Johnson questioning why the department had not reviewed the new tax appeal documents or why they had not reviewed Ascendiun's articles of incorporation or bylaws prior to approving the restructuring. Janet Rickershauser, a nonprofits lawyer at Hurwit & Associates, said that the bylaws are important to understanding the parent company's operations, including the relationship of the subsidiaries to each other and the holding parent company. In a letter sent June 23 to Johnson, Jonathon Williams, an assistant chief counsel at the DMHC, said the department concluded it was 'not necessary or appropriate' to review the tax-appeal documents in its review of Blue Shield's application to restructure nor conduct a 'full evaluation of Delaware's corporation statutory scheme.' The department told The Times that it conducted a 'comprehensive review' of the articles of incorporation of Blue Shield and its Medicaid Promise Health Plan as required by state law. Although it did not review Ascendiun's bylaws or articles of incorporation, the department said it retained its regulatory authority over Blue Shield. Blue Shield said it would not release it bylaws because they are 'confidential company documents.' However, Rickershauser said that 'hiding the ball on the bylaws is preventing transparency into important aspects of how they're operating.'
The Hill
an hour ago
- The Hill
5 people Trump could pick to replace Powell at Federal Reserve
President Trump is laying the groundwork to replace Federal Reserve Chair Jerome Powell as soon as he can. With less than a year left in Powell's term as Fed chair, Trump is eager to usher him toward the door and line up a replacement more aligned with the president's agenda. Trump said this week he's currently vetting 'three or four' candidates to be Fed chair, and that he could announce his pick well before Powell's term ends in May. Here are five front-runners for Trump's Fed nomination. Kevin Warsh has been in the running for a top Trump administration economic position since the president's first administration. This may finally be his moment. A former Morgan Stanley banker and George W. Bush economic advisor, Warsh became the youngest person to join the Fed board in 2006 at age 35. He served as the Fed's point man with Wall Street during the 2007-08 financial crisis and remained at the central bank through 2011. Warsh was among Trump's finalists to replace former Fed Chair Janet Yellen in 2018 but lost out to Powell — a Republican Fed governor with bipartisan credibility and a strong working relationship with then-Treasury Secretary Steven Mnuchin. After the 2024 election, Warsh was among several rumored candidates for Trump's Treasury secretary nomination and has met with the president at Mar-a-Lago. 'Trump has been vocal about his desire for a Fed that embraces lower rates and his ideal Fed chair candidate would be more pliant yet someone that the markets can accept with a degree of credibility. Kevin Warsh … could fit the bill,' wrote analysts at Beacon Policy Advisors. Fedwatchers have long considered Warsh the heir apparent to Powell given his close ties to Trump's orbit and willingness to call out the current central bank regime. Warsh has been fiercely critical of the Fed under Powell's leadership, accusing the bank of hiding behind its independence to avoid accountability. 'Independence is reflexively declared, all too often in my view, when the Fed is criticized,' Warsh said in an April speech to a conference in Washington, D.C. Warsh amped up his criticism earlier this month, denouncing central bankers as 'pampered princes' and defending Trump's attacks on the Fed. 'Central banks were created so that politicians would have someone to blame for this' he said. 'Well, grow up. Be tough.' Warsh also shares close political connections to Trump. His father-in-law, cosmetics heir Ronald Lauder, has donated millions of dollars to Trump and Republican candidates, and was reportedly behind Trump's quest to purchase Greenland. Bessent quickly cemented himself as Trump's chief dealmaker and Wall Street ambassador as the president's rocky tariff rollout roiled markets. The Treasury secretary was front and center as markets cratered, while urging Trump behind the scenes to refocus the bulk of his new tariffs toward Chinese goods. After Trump's pivot soothed markets, the president dispatched Bessent and U.S. Trade Representative Jamieson Greer to Switzerland, where they met with Chinese officials to broker a truce. The mission put Bessent squarely in the middle of Trump's orbit and established him as the de facto leader among the president's fractious economic team. Bessent has been tamer in his criticisms of the Fed and Powell than some of his White House colleagues since taking office, towing a careful line drawn between the Treasury and central bank more than seven decades ago. Even so, Bessent's loyalty to Trump and credibility with markets have put him in the conversation to succeed Powell. But his importance to Trump's overall economic agenda may dissuade the president from opening up a void in his administration. 'The president may not consciously acknowledge this dynamic but could be convinced that replacing Bessent with an alternative who can earn the trust of Wall Street would be a hassle. This doesn't mean that Trump wouldn't want Bessent helming the Fed, but that having to fill a vacancy at the Treasury Department would be creating a challenge where there doesn't need to be one,' Beacon analysts wrote. After decades as an economics professor and Fed research director, Waller joined the Fed board on Trump's nomination in 2020. Unlike four of Trump's other Fed nominees, Waller squeaked through the Senate in the waning days of the president's administration. He's largely been in sync with Powell on interest rates, but has voiced far less concern about the potential inflationary impact of Trump's tariffs and suggested cutting rates as soon as July. 'You'd want to start slow and bring them down, just to make sure that there's no big surprises. But start the process. That's the key thing,' Waller told CNBC last week. 'We've been on pause for six months to wait and see, and so far, the data has been fine. … I don't think we need to wait much longer, because even if the tariffs come in later, the impacts are still the same. It should be a one-off level effect and not cause persistent inflation.' Waller has also dismissed Trump's constant attacks on the Fed, arguing that the president's opinions alone do not harm the bank's independence. 'If the president wants to complain about it, he is free to do so just like everybody else,' Waller said in an interview with Bloomberg News after Trump's victory. 'That doesn't mean I have to listen or adjust policy to that, but he is entitled to every damn opinion he wants.' Bowman was nominated by Trump and confirmed by the Senate in 2018 to fill the first seat on the Fed board designated specifically for someone with community banking experience. Before joining the Fed, Bowman served as Kansas state banking supervisor and as vice president of Farmers & Drovers Bank. After keeping a relatively low profile as a Fed governor, Bowman scored a significant promotion when Trump nominated her earlier this year to serve as the central bank's vice chair of supervision. The role puts her in charge of the Fed's expansive regulatory portfolio and oversight of the biggest, most powerful U.S. banks. Like Waller, Bowman has generally voted with Powell in favor of loosening bank regulations and gradually reducing interest rates, but recently broke from the pack and called for a cut as soon as July. If nominated and confirmed to lead the Fed, she would be just the second woman to chair the central bank. Yellen was the first and held that position until she was replaced by Powell. While Hassett has served a variety of economic roles in both of Trump's administrations, he's shared one major goal among them: tout the benefits of the president's agenda when markets and the country at large are doubting it. Hassett was chair of the White House Council of Economic Advisers (CEA) during the first Trump administration, serving as the president's top economist amid major changes to tax, financial and trade policies. Now as director of the National Economic Council (NEC), Hassett has primarily been involved in crafting and modeling Trump's sweeping tariffs and domestic policy agenda, including extensions to key tax cuts passed during the first administration. Hassett is well known for his sunny demeanor even while fiercely defending Trump and his agenda on TV — an important balance for any of the president's top advisors. But Hassett has sharpened his criticism of the Fed and Powell as Trump's own tensions with the Fed chair boil over. 'There's absolutely no excuse, other than partisanship for the Fed not to cut rates,' Hassett said of his fellow Republican in an interview with Fox Business last week. Hassett in April also accused Powell of partisanship when discussing key issues. 'Having everybody that refused to warn about the runaway spending out there, saying, 'Oh, this is going to be a catastrophe for inflation because of the tariffs,' means that people need to improve their models and improve their messaging,' Hassett said. Powell, however, has warned under both Trump and Biden that the U.S. was on an 'unsustainable' fiscal path and needed to pay down its debt.
